Sept 16 (Reuters) - Amgen Inc said it will buy Netherlands-based Dezima Pharma B.V. for $300 million in cash and up to $1.25 billion in additional payments.
The deal adds Dezima's lead cholesterol drug, TA-8995, to Amgen's expanding portfolio of treatments for cardiovascular diseases.
(Reporting By Samantha Kareen Nair in Bengaluru; Editing by Anil D'Silva)
Finance expert Suze Orman has voiced concerns about the impact of climate change on property insurance costs, asserting it could threaten the American dream of homeownership. Orman, 72, faced a $28,000 annual insurance quote for her Florida oceanside condo, leading her to forego coverage entirely. She highlights a troubling trend where soaring insurance costs driven by frequent and severe weather events may deter Americans from buying homes. Don't Miss: For many first-time buyers, a house is abo
After Congress approved billions of extra funding for tax compliance, the Internal Revenue Service pledged it would get tougher on rich taxpayers and corporations while avoiding extra scrutiny of middle-class households.
Here's what could happen next to Meta Platforms' stock.
Six teams managing nearly $15 billion in total assets quit JPMorgan Chase’s brokerage unit to join competitors last Friday. Here’s what may have triggered their departures.
Advanced Micro (AMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With the recent halving and spot exchange-traded funds (ETFs) driving demand, Bitcoin has had the spotlight for much of 2024. However, according to Cathie Wood of Ark Invest, Ethereum (ETH) could catch up to Bitcoin and provide investors with huge profits in the coming years. At an investor conference held by Ark Invest, Wood spoke about Ethereum, noting that the project could reach a market capitalization of $20 trillion by 2032. ETH currently has a supply of around 120 million tokens. So, a ma
Several fired Google employees spoke at a press conference Monday about their experiences.
When it comes to reliable passive income, these three dividend-paying companies are best in breed.
Meta is working on something that's more immediately material to the business than what happens to TikTok.
Intel is underperforming the broader semiconductor index.